ProfileGDS4132 / 236017_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 43% 49% 32% 28% 45% 50% 35% 51% 27% 29% 22% 27% 22% 29% 21% 22% 32% 22% 24% 24% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101113.61643
GSM201543Muscle PCOS pioglitazone 121123.63149
GSM201544Muscle PCOS pioglitazone 16181.896732
GSM201545Muscle PCOS pioglitazone 20174.921828
GSM201829Muscle PCOS pioglitazone 231127.15645
GSM201830Muscle PCOS pioglitazon 251138.83350
GSM201831Muscle PCOS pioglitazone 27186.770535
GSM201832Muscle PCOS pioglitazone 31134.97151
GSM201833Muscle PCOS pioglitazone 4161.378727
GSM201834Muscle PCOS pioglitazone 8170.107529
GSM201835Muscle PCOS after pioglitazone 10239.499222
GSM201836Muscle PCOS after pioglitazone 12256.064727
GSM201837Muscle PCOS after pioglitazone 16240.380122
GSM201838Muscle PCOS after pioglitazone 20261.518529
GSM201839Muscle PCOS after pioglitazone 23241.869921
GSM201840Muscle PCOS after pioglitazone 25246.728222
GSM201841Muscle PCOS after pioglitazone 27265.015332
GSM201842Muscle PCOS after pioglitazone 3237.642322
GSM201843Muscle PCOS after pioglitazone 4254.94724
GSM201844Muscle PCOS after pioglitazone 8251.49824